EU medtech experts highlight need to get a grip on guidance
This article was originally published in RAJ Devices
Executive Summary
The over-reliance in the European Union medtech sector on producing non-mandatory guidance documents at the expense of legally enforceable regulations has led to a lack of consistency among EU member states in implementation. It is also leading to fragmentation and to a lack of credibility in the sector and the situation needs to be addressed urgently, according to senior UK devices regulator Steve Owen.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.